These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24446297)

  • 1. -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.
    Mandal S; Abebe F; Chaudhary J
    Genet Mol Res; 2014 Jan; 13(1):139-51. PubMed ID: 24446297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.
    Bao S; Yang W; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):693-6. PubMed ID: 19107369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
    Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
    Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
    Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
    Chen CH; Gong M; Yi QT; Guo JH
    Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.
    Iqbal MS; Peng K; Sardar N; Iqbal MH; Ghani MU; Tanvir F; Gu D; Guohua Z; Duan X
    Mol Immunol; 2023 Dec; 164():88-97. PubMed ID: 37989067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
    Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
    J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IL-6 promoter polymorphism hotspots (- 174G/C and - 572G/C) with cardiovascular disease risk factors.
    Tabrez S; Jabir NR; Zughaibi TA; Suhail M
    Mol Biol Rep; 2022 Mar; 49(3):2265-2272. PubMed ID: 35023009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
    Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
    Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the IL-6 -174G/C gene polymorphism with knee osteoarthritis in a Thai population.
    Honsawek S; Deepaisarnsakul B; Tanavalee A; Yuktanandana P; Bumrungpanichthaworn P; Malila S; Saetan N
    Genet Mol Res; 2011; 10(3):1674-80. PubMed ID: 21863560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.
    Jurečeková J; Drobková H; Šarlinová M; Babušíková E; Sivoňová MK; Matáková T; Kliment J; Halašová E
    Anticancer Res; 2018 Jun; 38(6):3663-3667. PubMed ID: 29848725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 promoter variants, prostate cancer risk, and survival.
    Tindall EA; Severi G; Hoang HN; Southey MC; English DR; Hopper JL; Giles GG; Hayes VM;
    Prostate; 2012 Dec; 72(16):1701-7. PubMed ID: 22782910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 gene -572G/C polymorphism and prostate cancer risk.
    Wang Y; Chen X; Chen Y
    Afr Health Sci; 2018 Jun; 18(2):267-272. PubMed ID: 30602952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of IL4-590C/T and IL6-174G/C Gene Polymorphisms in Type 2 Diabetic Patients With Chronic Kidney Disease in North Indian Population.
    Neelofar K; Ahmad J; Ahmad A; Alam K
    J Cell Biochem; 2017 Jul; 118(7):1803-1809. PubMed ID: 27996163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
    Zhai K; Yang Y; Gao ZG; Ding J
    Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease.
    Sen A; Paine SK; Chowdhury IH; Mukherjee A; Choudhuri S; Saha A; Mandal LK; Bhattacharya B
    Mol Vis; 2011; 17():2552-63. PubMed ID: 22025890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.
    Zhang H; Xu Y; Li L; Liu R; Ma B
    Urol Int; 2012; 88(4):447-53. PubMed ID: 22516897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.
    Magalhães JF; Cortinhas AJ; Albuquerque CM; Baptista CS; Ribeiro R; Viegas C; Matos A; Machado J; Pires MA; Guedes-Pinto H; Martins-Bessa A; Leitão JC; Bastos E
    Mol Biol Rep; 2013 Jan; 40(1):449-55. PubMed ID: 23073774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.
    Glymph S; Mandal S; Knowell AE; Abebe F; Chaudhary J
    Infect Genet Evol; 2013 Jun; 16():186-90. PubMed ID: 23438650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.